To meet the growing challenges of cancer care, our Disease Management Solutions empowers clinicians with powerful tools that can lead the way to more confident diagnosis and staging, treatment decisions, therapy planning and follow-up, and ultimately, provide a better way to address unmet needs in the ever-changing healthcare landscape.
The Philips Lung Cancer Orchestrator is an integrated lung cancer patient management system for both CT lung screening programs and incidental pulmonary findings programs that monitors patients through various steps of their lung cancer screening and treatment decision journey. Enhancing confidence with automated tools, the Lung Cancer Orchestrator helps identify and keep more patients – and streamline workflows. Providing a complete solution, the system also comes equipped with the Multidisciplinary Team Orchestrator to help facilitate collaborative clinical decision making.
Philips UroNav is designed to support you with image guidance during prostate biopsies and focal therapy procedures. It fuses diagnostic MR images of the prostate with live ultrasound images for guided procedures in real time. You get clear delineation of the prostate and suspicious lesions, as defined with DynaCAD Prostate¹, as well as clear visualization of the needle path. Combined with Philips DynaCAD Urology¹, you are equipped with a comprehensive solution supporting you at every step of the prostate cancer patient journey, enabling you to confidently deliver the precise care your patients deserve.
DynaCAD Prostate with Quibim QP-Prostate® AI brings fully automated outputs for prostate MRI analysis into a single platform — including AI-automated segmentation, lesion detection, and suspicion levels*. Designed to help radiologists streamline time-consuming prostate MRI review while keeping AI results accessible within the DynaCAD Prostate workflow.
You are now exiting the Philips United States (US) site and entering the Philips global site. This content is intended for a global audience. It may not apply to the US and should not be interpreted as meeting US standards, executive orders or regulations.
Continue